EAS - 医索

找到约 375 条结果

柳叶刀子刊发布全球痛风数据：男性患病率是女性的3倍

2024年7月9日，《Lancet Rheumatology》（IF=15.0）发表了关于痛风的全球疾病负担研究（Global Burden of Disease Study 2021），结果显示，2020年，全球有5580万人患有痛风，男性痛风患病率是女性的3.26倍。预计到2050年，痛风患病总数.....

学术资讯 - 临床医学

Phase ll study of sitravatinib in combination withtislelizumab in patients with advanced biliary tractcancer who have failed to at least 1 prior systemictreatment

医客学院 - 会议报告集

Trastuzumab and pertuzumab in combination witheribulin mesylate or a taxane as first-linechemotherapeutic treatment for HER2-positive, locallyadvanced or metastatic breast cancer results of amulti

医客学院 - 会议报告集

The ongoing Antibody-Drug conjugatesRevolution in Breast Cancer

医客学院 - 会议报告集

TBCRC 048(0laparib Expanded) Expansion cohortsPhase ll study of olaparib monotherapy in metastatic breast cancer(MBC) patients with germline(g) mutations in PALB2 orsomatic(s) mutations in BRCA1 O

医客学院 - 会议报告集

SACI-0 HR A randomized phase ll trial ofsacituzumab govitecan with or without pembrolizumabin patients with metastatic hormone receptor-positive!HER2-negative breast cancer

医客学院 - 会议报告集

Racial differences in genomic profilesand targeted treatment use in ER HER2-metastatic breast cancer

医客学院 - 会议报告集

Outcomes of Advanced MetastaticBreast Cancer(aMBC) Treated with Bria-lMT, an Allogeneic Whole-cell Immunotherapy

医客学院 - 会议报告集

LBA1000 DESTINY-Breast06

医客学院 - 会议报告集

H3B-6545 in women with locally advancedmetastaticestrogen receptor-positive,HER2-negative breast cancer

医客学院 - 会议报告集

首页
上一页
1
2
3
4
5
...
37
38
下一页
尾页

今日实时热搜